January 1, 2009Dalton Transactions

A novel ruthenium(ii) arene based intercalator with potent anticancer activity

View Full Paper

Ask AI

Bookmark

Abstract

The new ruthenium(II) compound [(eta6-p-cymene)Ru(N insertion mark C)Cl] (HN insertion mark C=9-aminoacridine (9-HAA)) shows a potent in vitro anticancer activity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ruiz et al. (2009) studied this question.

synapsesocial.com/papers/6a964b57ba6bcf74e4f904bb https://doi.org/10.1039/b907296a

View Full Paper

Ask AI

Bookmark

Abstract

The new ruthenium(II) compound [(eta6-p-cymene)Ru(N insertion mark C)Cl] (HN insertion mark C=9-aminoacridine (9-HAA)) shows a potent in vitro anticancer activity.